{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-263406","form_type":"8-K","ticker":"PCVX","cik":"0001649094","company_name":"Vaxcyte, Inc.","filed_at":"2024-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.102815+00:00","generated_at":"2026-05-29T20:51:16.006876+00:00","sec_items":["1.01","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Vaxcyte amends HQ lease to 258,581 RSF, subleases 16,731 SF to Iovance Biotherapeutics","bullets":["Amended lease expands premises from ~113k to 258,581 RSF across floors 1-6, phased move-ins Feb 2025 through June 2026.","Initial base rent $5.941-$6.026/RSF/month for existing premises; $6.00/RSF for additional; 8-month abatement, 3% annual escalations.","Lease term 120 months from first additional premises commencement, with two 5-year renewal options.","Subleased 16,731 RSF of Suite 100A to Iovance Biotherapeutics for 2 years at $5.95/RSF, rising to $6.1285/RSF after year one.","Security deposit of ~$1.09M in letters of credit carried over from prior leases."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-263406","json":"https://secwatch.observer/filing/0001193125-24-263406.json","markdown":"https://secwatch.observer/filing/0001193125-24-263406.md","text":"https://secwatch.observer/filing/0001193125-24-263406.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649094/000119312524263406/0001193125-24-263406-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649094/000119312524263406/d847442d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T20:51:16.006876+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}